GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Cash Flow from Discontinued Operations

Stealth BioTherapeutics (Stealth BioTherapeutics) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Mar. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Stealth BioTherapeutics's cash flow from discontinued operations for the three months ended in Mar. 2022 was $0.00 Mil. It means Stealth BioTherapeutics received $0.00 Mil from the sale of part of business quarterly. Stealth BioTherapeutics's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2022 was $0.00 Mil.


Stealth BioTherapeutics Cash Flow from Discontinued Operations Historical Data

The historical data trend for Stealth BioTherapeutics's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Cash Flow from Discontinued Operations Chart

Stealth BioTherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial - - - - -

Stealth BioTherapeutics Quarterly Data
Dec16 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Stealth BioTherapeutics Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stealth BioTherapeutics Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry
Traded in Other Exchanges
N/A
Address
c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005
Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.

Stealth BioTherapeutics (Stealth BioTherapeutics) Headlines

From GuruFocus

Stealth BioTherapeutics Corp Announces Completion of Merger

By PRNewswire PRNewswire 11-16-2022